• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Oct 21;14(1):24751.
doi: 10.1038/s41598-024-75519-6. New insights in the mechanism of the SARS-CoV-2 M[SUP]pro[/SUP] inhibition by benzisoselenazolones and diselenides

Luca Sancineto[SUP] 1 [/SUP], Francesca Mangiavacchi[SUP] 1 [/SUP], Agnieszka Dabrowska[SUP] 2 3 [/SUP], Agata J Pacuła-Miszewska[SUP] 4 [/SUP], Magdalena Obieziurska-Fabisiak[SUP] 4 [/SUP], Cecilia Scimmi[SUP] 1 [/SUP], Veronica Ceccucci[SUP] 1 [/SUP], Juan Kong[SUP] 5 [/SUP], Yao Zhao[SUP] 5 [/SUP], Gianluca Ciancaleoni[SUP] 6 [/SUP], Vanessa Nascimento[SUP] 7 [/SUP], Bruno Rizzuti[SUP] 8 9 [/SUP], Marco Bortoli[SUP] 10 [/SUP], Laura Orian[SUP] 11 [/SUP], Anna Kula-Pacurar[SUP] 2 [/SUP], Haitao Yang[SUP] 5 [/SUP], Jacek Ścianowski[SUP] 4 [/SUP], Ying Lei[SUP] 12 [/SUP], Krzysztof Pyrc[SUP] 13 [/SUP], Claudio Santi[SUP] 14 [/SUP]



Affiliations
Abstract

Although global vaccination campaigns alleviated the SARS-CoV-2 pandemic in terms of morbidity and mortality, the ability of the virus to originate mutants may reduce the efficacy of vaccines, posing a serious risk of a renewed pandemic. There is therefore a need to develop small molecules capable of targeting conserved viral targets, such as the main protease (M[SUP]pro[/SUP]). Here, a series of benzisoselenazolones and diselenides were tested for their ability to inhibit M[SUP]pro[/SUP]; then the most potent compounds were measured for antiviral activity in vitro, and the mechanism of action was investigated. Density functional theory calculations, molecular docking and molecular dynamics simulations were also used to elucidate the protein/drug interaction. Finally, a bio-organic model was established to study the reaction between selenorganic compounds and biologically relevant thiols to unveil possible metabolic pathways of such compounds. The overall results contribute to the identification of a series of novel Se-containing molecules active against SARS-CoV-2 and to the clarification of some important aspects in the mechanisms of action of such inhibitors targeting SARS-CoV-2 M[SUP]pro[/SUP].

Keywords: Benzisoselenazolones; Diselenides; Ebselen; Glutathione; SARS-CoV-2 main protease inhibitors.

 
Back
Top Bottom